Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability